Clinical Trials Browser

Phase EARLY_PHASE1 × Completed × Mesothelioma, Malignant × Clear all

NCT01722149 2019-08-07

Re-directed T Cells for the Treatment (FAP)-Positive Malignant Pleural Mesothelioma

Phase EARLY_PHASE1 Completed

Other solid neoplasmThoracic

Mesothelioma, Malignant, Pleural Effusion